---
title: "Driehaus Life Sciences Fund, Ltd. SEC filings"
url: https://altstreet.investments/edgar/1839220
kind: edgar-entity
updated: 2026-07-31
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Driehaus Life Sciences Fund, Ltd.: SEC filings and what they report

Driehaus Life Sciences Fund, Ltd. is a Cayman Islands-domiciled pooled investment fund managed by Driehaus Capital Management LLC, raising capital under Rule 506(b) and 3(c)(1). This amended filing reports $28.4M sold to 12 investors with a $1.0M minimum investment. The fund focuses on longevity and biotech strategies.

| Field | Value |
| --- | --- |
| Entity | Driehaus Life Sciences Fund, Ltd. |
| CIK | 1839220 |
| Filing family | 506(b), 3(c)(1) |
| Entity type | fund vehicle |
| Manager (as filed) | Driehaus Capital Management |
| Platform | Driehaus Life Sciences Fund, Ltd. (https://altstreet.investments/platforms/driehaus-life-sciences-fund-ltd) |
| Newest fact-bearing filing | January 16, 2026, accession 0001839220-26-000001 |
| Total sold (as reported) | $28,376,492 |
| Investors (as reported) | 12 |
| Minimum investment (as filed) | $1,000,000 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| n/a Driehaus Capital Management LLC | Promoter |
| Alex Munns | Executive Officer |
| Michael Caldwell | Executive Officer |
| Janet McWilliams | Executive Officer |
| Carrie O'Donnell | Director |
| Rachel Williams | Director |
| Tanya Campbell | Director |


## Filings (6 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| January 16, 2026 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1839220/000183922026000001/ |
| January 17, 2025 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1839220/000183922025000001/ |
| January 17, 2024 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1839220/000183922024000001/ |
| January 17, 2023 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1839220/000183922023000001/ |
| January 19, 2022 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1839220/000183922022000001/ |
| January 15, 2021 | D | Form D | https://www.sec.gov/Archives/edgar/data/1839220/000183922021000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1839220
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001839220&owner=include&count=40
- Other issuers on Driehaus Life Sciences Fund, Ltd.: https://altstreet.investments/deals/platform/driehaus-life-sciences-fund-ltd
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1839220
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.